Literature DB >> 18376858

Zwitterionic polymers exhibiting high resistance to nonspecific protein adsorption from human serum and plasma.

Jon Ladd1, Zheng Zhang, Shengfu Chen, Jason C Hower, Shaoyi Jiang.   

Abstract

This study examined six different polymer and self-assembled monolayer (SAM) surface modifications for their interactions with human serum and plasma. It was demonstrated that zwitterionic polymer surfaces are viable alternatives to more traditional surfaces based on poly(ethylene glycol) (PEG) as nonfouling surfaces. All polymer surfaces were formed using atom transfer radical polymerization (ATRP) and they showed an increased resistance to nonspecific protein adsorption compared to SAMs. This improvement is due to an increase in the surface packing density of nonfouling groups on the surface, as well as a steric repulsion from the flexible polymer brush surfaces. The zwitterionic polymer surface based on carboxybetaine methacrylate (CBMA) also incorporates functional groups for protein immobilization in the nonfouling background, making it a strong candidate for many applications such as in diagnostics and drug delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376858     DOI: 10.1021/bm701301s

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  75 in total

1.  Universal surface-initiated polymerization of antifouling zwitterionic brushes using a mussel-mimetic peptide initiator.

Authors:  Jinghao Kuang; Phillip B Messersmith
Journal:  Langmuir       Date:  2012-04-23       Impact factor: 3.882

Review 2.  Protein-polymer conjugation-moving beyond PEGylation.

Authors:  Yizhi Qi; Ashutosh Chilkoti
Journal:  Curr Opin Chem Biol       Date:  2015-09-07       Impact factor: 8.822

3.  Long circulating genetically encoded intrinsically disordered zwitterionic polypeptides for drug delivery.

Authors:  Samagya Banskota; Parisa Yousefpour; Nadia Kirmani; Xinghai Li; Ashutosh Chilkoti
Journal:  Biomaterials       Date:  2018-11-28       Impact factor: 12.479

4.  Covalent Grafting of Antifouling Phosphorylcholine-Based Copolymers with Antimicrobial Nitric Oxide Releasing Polymers to Enhance Infection-Resistant Properties of Medical Device Coatings.

Authors:  Qiaohong Liu; Priyadarshini Singha; Hitesh Handa; Jason Locklin
Journal:  Langmuir       Date:  2017-10-30       Impact factor: 3.882

5.  Preparation of compact biocompatible quantum dots using multicoordinating molecular-scale ligands based on a zwitterionic hydrophilic motif and lipoic acid anchors.

Authors:  Naiqian Zhan; Goutam Palui; Hedi Mattoussi
Journal:  Nat Protoc       Date:  2015-05-14       Impact factor: 13.491

6.  PEGylation of therapeutic oligonucletides: From linear to highly branched PEG architectures.

Authors:  Xueguang Lu; Ke Zhang
Journal:  Nano Res       Date:  2018-07-06       Impact factor: 8.897

7.  Sensitive and Quantitative Detection of Anti-Poly(ethylene glycol) (PEG) Antibodies by Methoxy-PEG-Coated Surface Plasmon Resonance Sensors.

Authors:  Peng Zhang; Fang Sun; Hsiang-Chieh Hung; Priyesh Jain; Kasey Joanne Leger; Shaoyi Jiang
Journal:  Anal Chem       Date:  2017-07-24       Impact factor: 6.986

8.  Overcoming nonviral gene delivery barriers: perspective and future.

Authors:  Charles H Jones; Chih-Kuang Chen; Anitha Ravikrishnan; Snehal Rane; Blaine A Pfeifer
Journal:  Mol Pharm       Date:  2013-10-16       Impact factor: 4.939

9.  Spatial charge configuration regulates nanoparticle transport and binding behavior in vivo.

Authors:  Hee-Sun Han; John D Martin; Jungmin Lee; Daniel K Harris; Dai Fukumura; Rakesh K Jain; Moungi Bawendi
Journal:  Angew Chem Int Ed Engl       Date:  2012-12-17       Impact factor: 15.336

10.  Lipoic acid glyco-conjugates, a new class of agents for controlling nonspecific adsorption of blood serum at biointerfaces for biosensor and biomedical applications.

Authors:  Yanyan Wang; Kheireddine El-Boubbou; Hovig Kouyoumdjian; Bin Sun; Xuefei Huang; Xiangqun Zeng
Journal:  Langmuir       Date:  2010-03-16       Impact factor: 3.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.